ubmslatePT-logo-ubm

PT Mobile Logo

Topics:

The news from phase 3 trials of psoriatic arthritis treatments is upbeat: certolizumab pegol (Cimzia), apremilast (Otezla), and secukinumab (Cosentyx) all continue to show positive effects.

I drive 100 miles up the Oregon coast to see my disabled patient Johnny. His blood pressure was excellent, and the view from the backyard? Priceless.

A study of adults from families with heavy genetic loading for bipolar disorder suggests that the disease has both neurodevelopmental and neurodegenerative underpinnings.

The goal of 90% skin clearance is “reachable” for many patients with severe psoriasis with interleukin-17 (IL-17) inhibitors. A closer look here.

Having been a resident not that many years ago, here is some advice for the new doctors as they take on the world.

GLP-1 receptor agonists may help patients with type 2 diabetes to lose weight by altering the way their brains respond to food.

What do current guidelines recommend as first-line treatment for patients like 51-year-old TK? Check out these options.

People who deserve shame in radiology.

Pages

Subscribe to Psychiatric Times RSS

By clicking Accept, you agree to become a member of the UBM Medica Community.